IntercontinentalExchange Inc’s bid for NYSE Euronext will now be reviewed by the European Commission to determine whether the deal is inline with EU antitrust law. The acquisition, offered at $8.2 billion, will place control of Europe’s second-largest derivatives market, Liffe, in ICE hands; it’s a move that will pit the company against rivals CME and Nasdaq OMX Group. Last year, ICE’s initial bid for NYSE failed. Earlier this year, the conglomerate requested that the European Commission review the deal as opposed to leaving the decision up to Portugal, Spain and Britain authorities.
Featured News
Republican Senators Introduce Bill to Repeal California Vehicle Emissions Waivers
Aug 6, 2026 by
CPI
Mexican Unions Split Over Antitrust Risks in Volaris-Viva Merger
Aug 6, 2026 by
CPI
Nuclear Power Companies Win Early Dismissal of Worker Wage-Fixing Suit
Aug 6, 2026 by
CPI
FCC Vote on TV Ownership Cap Draws Fresh Scrutiny Over Media Consolidation
Aug 6, 2026 by
CPI
Vail, Alterra Face Antitrust Suit Alleging Ski Pass Pricing Scheme
Aug 6, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes